Table 5.
Family | Features | Cytokines | Receptors |
---|---|---|---|
TNF | Contain highly conserved carboxy terminal domains; can induce receptor trimerization influencing signaling pathways | TNF RI (p55), TNF RII (p75), LT-β R, Fas (CD95), TRAIL R3, CD27, TNF R21 (DR6) | |
γc | Receptors contain a common γchain (γc) | IL-2 | |
IL-4 & IL-13 | Bind to shared heteromultimeric receptor complexes | IL-13 Rα1 | |
βc | Receptors contain a common βchain (βc) | IL-5 Rα, GM-CSF Rα | |
IL-1 | A superfamily of proteins comprised of IL-1 and IL-18 members. | IL-1RA | IL-1 RI, IL-1 RII, , IL-1R AP, IL-18 BP |
IGF | Share sequence homology with the insulin family of proteins | IGF1a, IGF2 | IGF RII |
HGF & MSP | Contain a 4-kringle domain and a pseudo-serine protease domain that lacks enzyme activity | Met | |
FGF | Heparin-binding polypeptides | FGF R1, FGF R2, FGF R4 | |
Neutrophic factors | Induce signal transduction through ligand-induced dimerization and activation of trk receptors | trk B | |
PDGF, VEGF, PlGF | Dimeric angiogenic factors containing an 8-cysteine motif | PDGF-B, VEGF-D | PDGF Rβ, VEGF R1, VEGF R2, VEGF R3, Neuropilin-1, Neuropilin-2 |
EGF | Contain at least one extracellular EGF structural unit (conserved 6-cysteine motif that forms 3 disulfide bonds) | EGF R | |
gp130 | Receptors of the IL-6 superfamily are homologous to or contain the gp130 subunit as the common signaling component | OB | Ob R, OSM R, IL-6 Rα, IL-6 Rβ (gp130), CNTF Rα |
SCF, Flt-3L, M-CSF | Contain a 4-helix bundle structure in the extracellular domain and 4 conserved cysteines; receptors are tyrosine kinases | Flt-3L, M-CSF | c-kit, Flt-3, M-CSF R |
MK & PTN | Products of retinoic acid-responsive genes; developmentally-regulated molecules | RPTPβ | |
TGF-β | Contain a highly conserved 7-cysteine domain that forms a characteristic cysteine knot | TGF-β1, TGF-β3, BMP-1, BMP-3, GDF-2, Inh β C, Inh β E | TGF-β RII, TGF-β RIII, BMPR-II, GFRα2, Act RII, |
CC chemokine | Target population include: lymphoid cells (T cells and NK cells), monocytes and PMNs | HCC-1, MIP-1d , HCC-4, 6Ckine, Eot-2, CTACK, | CCR5, CCR10 |
CXC chemokine | Target population include: predominantly PMNs, but also T and B cells | PF4, CXCL16 | |
Unique | IL-32, MIF | GH R, IFN-α/α Rα, IFN- α/β Rβ, IL-10 Rα, IL-10 Rβ, IL-17 R, IL-23 R, IL-31 Rα, TLR4 |
Cytokine nomenclature and categorization are from http://www.rndsystems.com and Ref. 57. TNF, tumor necrosis factor; LT-β, lymphotoxin beta; TRAIL, TNF-related apoptosis-inducing ligand; DR6, death receptor 6; IL, interleukin; GM-CSF, granulocyte macrophage colony stimulating factor; IL-1RA, interleukin 1 receptor antagonist; IL-1R AP, interleukin 1 receptor accessory protein; IL-18 BP, interleukin 18 binding protein; IGF, insulin-like growth factor; HGF, hepatocyte growth factor; MSP, macrophage stimulating protein; Met, hepatocyte growth factor receptor; FGF, fibroblast growth factor; trk B, neurotrophic tyrosine kinase receptor type 2; PDGF, platelet-derived growth factor; VEGF, vascular endothelial growth factor; PlGF, placenta growth factor; EGF, epidermal growth factor; OB, leptin; OSM, oncostatin M; CNTF, ciliary neurotrophic factor; SCF, stem cell factor; Flt-3L, fms-like tyrosine kinase 3 ligand; M-CSF, macrophage-colony stimulating factor; c-kit, SCF receptor; MK, midkine; PTN, pleiotrophin; RPTPβ, receptor-type tyrosine-protein phosphatase beta; TGF, transforming growth factor; BMP, bone morphogenetic protein; GDF, growth/differentiation factor; Inh β C, inhibin beta C chain; Inh β E, inhibin beta E chain; GFR, glial-derived neurotrophic factor receptor; Act, activin; NK cells, natural killer cells; PMN, polymorphonuclear leukocytes; HCC, hemofiltrate CC (a class of chemokines); MIP, macrophage inflammatory protein; 6Ckine, 6-cysteine chemokine; Eot, eotaxin; CTACK, cutaneous T cell-attracting chemokine; CCR, CC chemokine receptor; PF4, platelet factor 4; CXCL16, CXC-chemokine ligand 16; MIF, macrophage migration inhibitory factor; GH R, growth hormone receptor; IFN, interferon; TLR, toll-like receptor.